Janus Henderson Global Life Sciences Fund Class I (JFNIX)

Fund Assets	4.22B
Expense Ratio	0.77%
Min. Investment	$1,000,000
Turnover	n/a
Dividend (ttm)	4.00
Dividend Yield	6.12%
Dividend Growth	34.89%
Payout Frequency	Annual
Ex-Dividend Date	Dec 6, 2024

Previous Close	65.42
YTD Return	-3.97%
1-Year Return	-8.58%
5-Year Return	33.80%
52-Week Low	61.84
52-Week High	82.79
Beta (5Y)	0.62
Holdings	108
Inception Date	Jul 6, 2009

About JFNIX

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: JFNIX
• Share Class: Class I
• Index: MSCI World/Health Care NR

Performance

JFNIX had a total return of -8.58% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.96%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
JFNNX	Class N	0.68%
JNGLX	Class D	0.80%
JAGLX	Class T	0.92%
JFNAX	Class A	0.98%

Top 10 Holdings

39.11% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	9.78%
UnitedHealth Group Incorporated	UNH	5.36%
AstraZeneca PLC	AZN	4.07%
Boston Scientific Corporation	BSX	3.20%
Sanofi	SAN	3.18%
Abbott Laboratories	ABT	3.06%
Vertex Pharmaceuticals Incorporated	VRTX	2.93%
AbbVie Inc.	ABBV	2.57%
Amgen Inc.	AMGN	2.51%
Novartis AG ADR	NVSN.MX	2.44%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 6, 2024	$3.99969	Dec 6, 2024
Dec 7, 2023	$2.96525	Dec 7, 2023
Dec 20, 2022	$0.20212	Dec 20, 2022
Dec 20, 2021	$6.8555	Dec 20, 2021
Dec 17, 2020	$5.6057	Dec 17, 2020
Dec 17, 2019	$3.85556	Dec 17, 2019